Technology continues to play a pivotal role in healthcare and the shift from paper-based prescriptions to electronic formats has improved efficiency, safety and convenience for
Transitions of care are pivotal moments in healthcare delivery, where patients move between different healthcare settings. Whether transitioning from hospital to home, or from home
PDL has chosen to describe the charting and prescribing activity by hospital pharmacists as Collaborative Pharmacist-led Charting and Prescribing (CPCP), though it may also be
This Practice Alert highlights some recent practice issues reported to PDL Professional Officers. Respiratory Syncytial Virus (RSV) vaccines Currently, two Respiratory Syncytial Virus (RSV) vaccines,
During your healthcare career, you may receive a regulatory notification. Regulatory notifications are a mechanism for the public to raise any concerns about their healthcare experience
The Pharmacists’ Support Service (PSS) and Pharmaceutical Defence Limited (PDL) are pleased to announce the inaugural winner of the John Coppock Pharmacist Wellbeing Award. Announcing
PDL has recently released the Practice Alert ‘Be aware or beware of wrong patient errors – part 1’. This second alert follows up to provide
From 1 October 2024, therapeutic vapes with a nicotine concentration of 20mg/mL or less will be available in pharmacies to patients 18 years or over
Notice is hereby given that the 112th Annual General Meeting of Pharmaceutical Defence Limited will be a hybrid meeting, both in person at Suite 3,
Pharmacists are likely aware that Wegovy® (semaglutide) is now available in Australia. The PDL Professional Officers have received several incident reports involving patients being supplied
Pharmaceutical Defence Limited (PDL) acknowledges the Traditional Owners of Country throughout Australia and their continuing connection to land, waters and community. We pay our respects to the people, the cultures and the Elders past and present.